2012
DOI: 10.1002/14651858.cd007179.pub2
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Antibiotics for treating human brucellosis

Abstract: Doxycycline (six weeks) plus streptomycin (two or three weeks) regimen is more effective regimen than doxycycline plus rifampicin (six weeks) regimen. Since it needs daily intramuscular (IM) injection, access to care and cost are important factors in deciding between two choices. Quinolone plus rifampicin (six weeks) regimen is slightly better tolerated than doxycycline plus rifampicin, and low quality evidence did not show any difference in overall effectiveness.

Search citation statements

Order By: Relevance

Paper Sections

Select...
88
34
29
1

Citation Types

2
102
0
13

Year Published

Range
2000
2000
2026
2026

Publication Types

Select...
115
22
5
4

Relationship

0
146

Authors

Journals

citations

Cited by 145 publications

(117 citation statements)
references

References 51 publications

2
102
0
13
Order By: Relevance
How this paper cites the one you are viewing
“…This review updates the synthesis of evidence available for therapeutic interventions for treating human brucellosis with the differential of using a more comprehensive approach based on indirect comparisons made possible by network meta-analyses. The results are in line with those of previous studies, confirming the superiority of the doxycycline + streptomycin regimen for six weeks compared to doxycycline + rifampicin [12,15]. Therapeutic regimens based on binary combinations, including doxycycline, predominate in the literature.…”
Section: Discussion
supporting
confidence: 88%
“…Karami et al (2020) [55], evaluating the same intervention in 2020 in eight and 12 weeks, also did not identify the superiority of the longer treatment in relation of recurrence. In the findings of this review and those published previously [12,15], the superiority of aminoglycoside regimens is well established. However, the use of triple therapy remains a factor under evaluation, either by proving the superiority or even indicating the appropriate treatment time.…”
Section: Assessment Of Risk Of Bias
mentioning
confidence: 67%
See 1 more Smart Citation